US Stock MarketDetailed Quotes
AGXRW AGILE THERAPEUTICS INC C/WTS 13/10/2026 (TO PUR COM)
- 0.000
- 0.0000.00%
15min DelayClose Aug 13 16:00 ET
8.30KMarket Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)83.03MShares0.00052wk High0.00P/B3.77KFloat Cap0.00052wk Low--Dividend TTM37.65MShs Float0.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
AGILE THERAPEUTICS INC C/WTS 13/10/2026 (TO PUR COM) Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 102.74%233K | -55.24%-2.48M | 73.36%-9.58M | 111.03%172K | 102.19%365K | -190.35%-8.52M | 89.19%-1.6M | 44.87%-35.95M | 90.62%-1.56M | 10.10%-16.7M |
| Net income from continuing operations | -211.90%-11.87M | 123.82%1.28M | 43.08%-14.47M | -13.71%-4.47M | 86.54%-798K | 26.34%-3.81M | 48.10%-5.39M | 64.24%-25.41M | 79.87%-3.93M | 64.66%-5.93M |
| Operating gains losses | 646.83%9.15M | -149.14%-4.2M | 53.05%-6.76M | 103.88%130K | -35.00%-3.53M | 76.26%-1.67M | -21.89%-1.69M | -276.22%-14.4M | ---3.35M | ---2.61M |
| Depreciation and amortization | 7.37%102K | 10.75%103K | -74.84%386K | 9.89%100K | -62.60%98K | -83.98%95K | -84.18%93K | -30.99%1.53M | -84.17%91K | -52.54%262K |
| Other non cash items | --0 | -56.03%135K | -46.01%1.06M | -32.63%225K | -69.93%252K | -26.19%279K | -26.73%307K | 18.54%1.97M | -16.29%334K | 110.55%838K |
| Change In working capital | 165.91%2.57M | -102.79%-128K | 393.16%7.42M | -35.47%2.82M | 139.84%3.9M | -150.92%-3.89M | 196.44%4.58M | 11.32%-2.53M | 341.47%4.38M | -93.62%-9.8M |
| -Change in receivables | 119.66%263K | -659.45%-1.42M | 99.19%-15K | -61.38%129K | 157.88%940K | -131.46%-1.34M | 105.28%254K | -176.05%-1.84M | 249.11%334K | -1,043.66%-1.62M |
| -Change in inventory | -529.23%-2.05M | -14.90%-1.01M | -189.25%-2.21M | -1,758.82%-1.13M | -76.98%125K | -192.07%-325K | 49.10%-879K | 87.87%-763K | 104.81%68K | 138.43%543K |
| -Change in prepaid assets | -127.28%-440K | -87.69%32K | 157.95%2.27M | -108.64%-210K | 121.54%607K | 188.04%1.61M | -63.22%260K | 191.00%880K | 3,064.63%2.43M | -96.10%-2.82M |
| -Change in payables and accrued expense | 229.53%4.88M | -53.08%2.36M | 1,324.20%7.69M | 159.68%4.12M | 139.48%2.31M | -247.80%-3.77M | 359.00%5.03M | -112.07%-628K | -42.15%1.59M | -188.19%-5.86M |
| -Change in other current liabilities | -16.88%-90K | -12.99%-87K | -82.29%-319K | -95.35%-84K | -92.86%-81K | -11.59%-77K | -266.67%-77K | -33.59%-175K | -48.28%-43K | -16.67%-42K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 102.74%233K | -55.24%-2.48M | 73.36%-9.58M | 111.03%172K | 102.19%365K | -190.35%-8.52M | 89.19%-1.6M | 44.87%-35.95M | 90.62%-1.56M | 10.10%-16.7M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -100.34%-133K | 0 | 0 |
| Net PPE purchase and sale | --0 | --0 | --0 | --0 | --0 | --0 | --0 | 50.56%-133K | --0 | --0 |
| Net investment purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | --0 | --0 | --0 | --0 | -100.34%-133K | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 225.84%2.54M | -68.95%6.89M | -173.79%-487K | -102.83%-278K | -43.76%6.88M | 248.76%778K | -27.08%22.18M | -96.87%660K | 334.17%9.82M |
| Net issuance payments of debt | --0 | -718.22%-1.84M | 92.25%-1.35M | -116.89%-488K | 97.14%-348K | ---286K | 95.50%-225K | ---17.38M | ---225K | ---12.15M |
| Net common stock issuance | --0 | --0 | -76.76%8.24M | -99.89%1K | -70.06%6.58M | -94.67%652K | 188.22%1M | 16.75%35.43M | -95.80%886K | 871.31%21.97M |
| Net preferred stock issuance | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --4.13M | ---1K | --0 |
| Proceeds from stock option exercised by employees | --0 | --4.38M | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | 225.84%2.54M | -68.95%6.89M | -173.79%-487K | -102.83%-278K | -43.76%6.88M | 248.76%778K | -27.08%22.18M | -96.87%660K | 334.17%9.82M |
| Net cash flow | ||||||||||
| Beginning cash position | -40.96%2.62M | -51.28%2.56M | -72.60%5.25M | -53.25%2.87M | -78.62%2.79M | 18.33%4.43M | -72.60%5.25M | 32.36%19.14M | -58.30%6.15M | -50.12%13.03M |
| Current changes in cash | 114.17%233K | 107.22%59K | 80.65%-2.69M | 64.85%-316K | 101.28%88K | -117.71%-1.64M | 94.69%-817K | -396.94%-13.9M | -120.39%-899K | 39.54%-6.88M |
| End cash Position | 2.26%2.85M | -40.96%2.62M | -51.26%2.56M | -51.26%2.56M | -53.25%2.87M | -78.62%2.79M | 18.33%4.43M | -72.60%5.25M | -72.60%5.25M | -58.30%6.15M |
| Free cash flow | 102.74%233K | -55.24%-2.48M | 73.46%-9.58M | 111.03%172K | 102.19%365K | -189.66%-8.52M | 89.28%-1.6M | 44.89%-36.08M | 90.65%-1.56M | 10.42%-16.7M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data